INS and Hypoglycemia: Other reported risks include suicidal ideation, insomnia, oligohidrosis and hyperthermia, cognitive slowing, slowing of linear growth, metabolic acidosis, hypokalemia, decreased renal function, kidney stones, seizures with abrupt withdrawal among individuals with a history of seizures, hypoglycemia in T2D if on insulin or insulin secretagogues, and acute angle glaucoma [116].